Telmisartan 40 mg + Metoprolol Succinate ER 25 mg Tablets – Dual benefits with extended relief for high-risk patients
SOTEL M Tablets – Metoprolol 25mg (extended-release) + Telmisartan 40mg bilayered tablets combines two active agents: Telmisartan, an angiotensin II receptor blocker (ARB), and Metoprolol, a beta-blocker. Telmisartan helps lower blood pressure by relaxing blood vessels, while Metoprolol reduces heart rate and cardiac workload by blocking beta receptors in the heart. This combination is used to manage hypertension (high blood pressure) and is also beneficial for patients with heart conditions like angina or heart failure.
Recommended by specialists:
✅ Cardiologist: To manage cardiovascular conditions like angina, heart failure and arrhythmia.
✅ General physician: To treat Hypertension- high blood pressure
Key benefits of Telmisartan 40 mg + Metoprolol Succinate ER 25 mg Tablets – SOTEL M Tablets
✅ Dual Mechanism: This combination offers improved blood pressure management by targeting two different mechanisms—Telmisartan relaxes blood vessels, while Metoprolol decreases heart rate and cardiac contractility.
✅ Ideal for High-Risk Patients: Beyond lowering blood pressure, it reduces cardiac workload, making it particularly beneficial for individuals at high risk of heart failure, angina, or myocardial infarction.
✅ Complementary Action: Metoprolol mitigates the overactivity of the sympathetic nervous system, commonly seen in hypertensive patients, while Telmisartan works by inhibiting vasoconstriction triggered by angiotensin II.
✅ Full day effect: Extended release of Metoprolol provides prolonged effect and reduces dose frequency.
Indications:
✅ Hypertension
✅ Angina pectoris
✅ Heart failure management
✅ Arrhythmia control